BFC Planning’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$924 Hold
78
– – ﹤0.01% 3177
2026
Q2
$1.03K Hold
78
– – ﹤0.01% 3146
2026
Q1
$2.05K Hold
78
– – ﹤0.01% 2591
2025
Q4
$19.4K Hold
78
– – ﹤0.01% 1764
2025
Q3
$16.4K Buy
+78
New +$13.8K ﹤0.01% 1679
2025
Q2
– Sell
-78
Closed -$6.88K – 2742
2025
Q1
$6.88K Hold
78
– – ﹤0.01% 1910
2024
Q4
$5.65K Sell
78
-26
-25% -$1.78K ﹤0.01% 1976
2024
Q3
$8.24K Buy
+104
New +$8K ﹤0.01% 1831

Other funds holding GOSS

BFC Planning's GOSS Position: Q3 2026 in Review

BFC Planning held its Gossamer Bio (GOSS) position steady in Q3 2026 at 78 shares worth $924. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

BFC Planning first reported a position in GOSS in Q3 2024 and has held it in 8 quarters since. The position peaked at $19.4K in Q4 2025. 50 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • BFC Planning held 78 shares of Gossamer Bio worth $924 as of Q3 2026.
  • BFC Planning left its Gossamer Bio share count unchanged in Q3 2026.
  • Gossamer Bio made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3177 holding.
  • BFC Planning first reported a position in Gossamer Bio in Q3 2024 and has held it in 8 quarters since.
  • BFC Planning's Gossamer Bio position peaked at $19.4K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.